MannKind | Salg



Sales Endring Dato
Adma Biologics USD 117.55M 2.29M 2024-12
Dynavax Technologies USD 72.03M 8.6M 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Insmed USD 104.44M 11.02M 2024-12
MacroGenics USD 19.35M 91.35M 2024-12
MannKind USD 76.78M 6.7M 2024-12
Merck USD 15.62B 1.03B 2024-12
Novo Nordisk DKK 85.68B 14.37B 2024-12
Pfizer USD 17.76B 61M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
Xencor USD 70.02M 59.31M 2024-12



MannKind Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.